Clinical Trials Directory

Trials / Completed

CompletedNCT03205228

Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors

Treatment Outcomes in Patients With Globus: A Randomized Control Trial of Psychoeducation, Anxiolytics and Proton Pump Inhibitors

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomized controlled trial study is conducted to compare treatment efficacy between psycho-education, anxiolytics drug and proton pump inhibitors in participants who met the criteria of globus.

Detailed description

This is a randomized controlled trial in patients with globus. All participants will be allocated into 3 groups (16 subjects/group) : Proton pump inhibitors (miracid®) , anxiolytics drug (Deanxit®) and psycho-education. The study duration is 4 weeks long. Data regarding clinical severity and quality of life of all participants will be collected at the beginning and at the end of treatment.

Conditions

Interventions

TypeNameDescription
DRUGOmeprazoleA capsule of Omeprazole 20 mg \& 1 capsule of placebo will be given in individual subject, once daily for 4 weeks. Both drugs will be presented in the same appearance (white capsule).
BEHAVIORALpsychoeducationPsychoeducation will be given by psychologists at the Day 1 and Day 15 of the study period.One white capsule of placebo will be given once daily for 4 weeks of the study period.
DRUGFlupentixol +MelitracenA capsule containing of a tablet of melitracen 10 mg + flupentixol 0.5 mg \& a capsule of placebo will be given once daily, for 4 weeks. Both would be presented in the same appearance (white capsule)

Timeline

Start date
2017-07-07
Primary completion
2018-06-26
Completion
2018-07-28
First posted
2017-07-02
Last updated
2018-08-22

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03205228. Inclusion in this directory is not an endorsement.